Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(34), p. 3579-3579

DOI: 10.1200/jco.2016.34.15_suppl.3579

Links

Tools

Export citation

Search in Google Scholar

Genetic variants of ATM and XRCC3 to predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO